NG
REGN icon

NatWest Group’s Regeneron Pharmaceuticals REGN Stock Holding History

NatWest Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,906
Closed -$887K – 292
2015
Q3 		$887K Buy
+1,906
New +$1.02M 0.02% 209
2015
Q2 		– Sell
-1,900
Closed -$858K – 417
2015
Q1 		$858K Buy
1,900
+321
+20% +$136K 0.01% 236
2014
Q4 		$648 Buy
1,579
+872
+123% +$343K 0.01% 274
2014
Q3 		$255 Buy
+707
New +$237K ﹤0.01% 458
2014
Q1 		– Sell
-6,494
Closed -$1.79M – 673
2013
Q4 		$1.79M Buy
6,494
+972
+18% +$280K 0.05% 293
2013
Q3 		$1.73M Sell
5,522
-11,815
-68% -$3.11M 0.05% 285
2013
Q2 		$3.9M Buy
+17,337
New +$4.04M 0.08% 223

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $677M AUM 27.58% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return